Defining conversion therapy for esophageal squamous cell carcinoma. Issue 1 (19th October 2022)

• Record Type: Journal Article
• Authors: Matsuda, Satoru; Tsushima, Takahiro; Kato, Ken; Hsu, Chih‐Hung; Lee, Jang Ming; Wong, Ian Yu‐Hong; Wang, Hu‐Lin Christina; Kang, Chang Hyun; Guo, Xufeng; Yamamoto, Shun; Tsuji, Takayuki; Kawakubo, Hirofumi; Takeuchi, Hiroya; Law, Simon; Kitagawa, Yuko
• Is Part Of: Annals of gastroenterological surgery. Volume 7:Issue 1(2023)
• Page Start: 7
• Page End: 9
• Publication Date: 2022-10-19
• Subjects: conversion surgery -- conversion therapy -- esophageal squamous cell carcinoma; Digestive organs -- Surgery -- Periodicals; 617.43
• DOI: 10.1002/ags3.12623
• Languages: English
• ISSNs: 2475-0328

Abstract

Abstract : A multimodality treatment conference with experts from across East Asia was held to establish a consensus for conversion therapy. An agreement was reached that conversion therapy was defined as surgery or chemoradiotherapy (CRT) aiming at cure after initial treatment for tumors that were initially unresectable due to adjacent organ invasion or distant metastasis.